Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 3,045.00
+375.00 (14.04%)
At close: Oct 2, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 10.89 billion as of October 2, 2026. Its market cap has decreased by -37.67% in one year.
Market Cap
10.89B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
9.26
Stock Price
3,045.00
ChartMarket Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 10.89B, a decrease of -53.78%. That is a compound annual growth rate of -22.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 10.89B | -14.47% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 25.20B |
| Seoul Pharma | 22.61B |
| Daesung Microbiological Labs. | 22.57B |
| BIFIDO | 21.84B |
| Hurum | 20.40B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 18.65B |
| CXI Healthcare Technology Group | 17.34B |